Prediction model for high glycated hemoglobin concentration among ethnic Chinese in Taiwan

Cardiovascular Diabetology

Volumn 9, Issue , 2010, Pages

  Chien, Kuo Liong ^a,b   Lin, Hung Ju ^b   Lee, Bai Chin ^b   Hsu, Hsiu Ching ^b   Chen, Ming Fong ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN;

ADULT; AGE DISTRIBUTION; ARTICLE; BODY MASS; CHINESE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; ETHNIC GROUP; FAMILY HISTORY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREVALENCE; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SYSTOLIC BLOOD PRESSURE; TAIWAN; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; AGED; ASIAN; ETHNOLOGY; HYPERGLYCEMIA; METABOLISM; MIDDLE AGED; MULTIVARIATE ANALYSIS; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; RISK FACTOR; STATISTICAL MODEL; STATISTICS;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERGLYCEMIA; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; TAIWAN;

EID: 77957150261     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-9-59     Document Type: Article

References (52)

1. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998, 352(9131):837-853. 10.1016/S0140-6736(98)07019-6, 9742976.
2. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, Hadden D, Turner RC, Holman RR. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Bmj 2000, 321(7258):405-412. 10.1136/bmj.321.7258.405, 27454, 10938048.
3. Khaw KT, Wareham N, Luben R, Bingham S, Oakes S, Welch A, Day N. Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European prospective investigation of cancer and nutrition (EPIC-Norfolk). Bmj 2001, 322(7277):15-18. 10.1136/bmj.322.7277.15, 26599, 11141143.
4. Liu QZ, Pettitt DJ, Hanson RL, Charles MA, Klein R, Bennett PH, Knowler WC. Glycated haemoglobin, plasma glucose and diabetic retinopathy: cross-sectional and prospective analyses. Diabetologia 1993, 36(5):428-432. 10.1007/BF00402279, 8314447.
5. Schulze MB, Shai I, Manson JE, Li T, Rifai N, Jiang R, Hu FB. Joint role of non-HDL cholesterol and glycated haemoglobin in predicting future coronary heart disease events among women with type 2 diabetes. Diabetologia 2004, 47(12):2129-2136. 10.1007/s00125-004-1593-2, 15662553.
6. Park PJ, Griffin SJ, Sargeant L, Wareham NJ. The performance of a risk score in predicting undiagnosed hyperglycemia. Diabetes Care 2002, 25(6):984-988. 10.2337/diacare.25.6.984, 12032103.
7. Al-Lawati JA, Tuomilehto J. Diabetes risk score in Oman: A tool to identify prevalent type 2 diabetes among Arabs of the Middle East. Diabetes Res Clin Pract 2007, 77(3):438-444. 10.1016/j.diabres.2007.01.013, 17306410.
8. Glumer C, Vistisen D, Borch-Johnsen K, Colagiuri S. Risk scores for type 2 diabetes can be applied in some populations but not all. Diabetes Care 2006, 29(2):410-414. 10.2337/diacare.29.02.06.dc05-0945, 16443896.
9. Ramachandran A, Snehalatha C, Vijay V, Wareham NJ, Colagiuri S. Derivation and validation of diabetes risk score for urban Asian Indians. Diabetes Res Clin Pract 2005, 70(1):63-70. 10.1016/j.diabres.2005.02.016, 16126124.
10. Kanaya AM, Wassel Fyr CL, de Rekeneire N, Shorr RI, Schwartz AV, Goodpaster BH, Newman AB, Harris T, Barrett-Connor E. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care 2005, 28(2):404-408. 10.2337/diacare.28.2.404, 15677800.
11. Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB. Prediction of Incident Diabetes Mellitus in Middle-aged Adults: The Framingham Offspring Study. Arch Intern Med 2007, 167(10):1068-1074. 10.1001/archinte.167.10.1068, 17533210.
12. Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M, Pfeiffer AF, Spranger J, Thamer C, Haring HU, et al. An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. Diabetes Care 2007, 30(3):510-515. 10.2337/dc06-2089, 17327313.
13. Wannamethee SG, Shaper AG, Lennon L, Morris RW. Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005, 165(22):2644-2650. 10.1001/archinte.165.22.2644, 16344423.
14. Silventoinen K, Pankow J, Lindstrom J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil 2005, 12(5):451-458. 10.1097/01.hjr.0000174793.31812.21, 16210931.
15. McNeely MJ, Boyko EJ, Leonetti DL, Kahn SE, Fujimoto WY. Comparison of a clinical model, the oral glucose tolerance test, and fasting glucose for prediction of type 2 diabetes risk in Japanese Americans. Diabetes Care 2003, 26(3):758-763. 10.2337/diacare.26.3.758, 12610034.
16. Lindstrom J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003, 26(3):725-731. 10.2337/diacare.26.3.725, 12610029.
17. Stern MP, Williams K, Haffner SM. Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?. Ann Intern Med 2002, 136(8):575-581.
18. von Eckardstein A, Schulte H, Assmann G. Risk for diabetes mellitus in middle-aged Caucasian male participants of the PROCAM study: implications for the definition of impaired fasting glucose by the American Diabetes Association. Prospective Cardiovascular Munster. J Clin Endocrinol Metab 2000, 85(9):3101-3108. 10.1210/jc.85.9.3101, 10999793.
19. Thomas C, Hypponen E, Power C. Type 2 diabetes mellitus in midlife estimated from the Cambridge Risk Score and body mass index. Arch Intern Med 2006, 166(6):682-688. 10.1001/archinte.166.6.682, 16567609.
20. Chien KL, Lee BC, Hsu HC, Lin HJ, Chen MF, Lee YT. Prevalence, agreement and classification of various metabolic syndrome criteria among ethnic Chinese: A report on the hospital-based health diagnosis of the adult population. Atherosclerosis 2008, 196(2):764-771. 10.1016/j.atherosclerosis.2007.01.006, 17291512.
21. Chien KL, Hsu HC, Lee YT, Chen MF. Renal function and metabolic syndrome components on cardiovascular and all-cause mortality. Atherosclerosis 2008, 197(2):860-867. 10.1016/j.atherosclerosis.2007.07.037, 17854811.
22. Chien KL, Hsu HC, Chao CL, Lee BC, Chen MF, Lee YT. Interaction of obesity, metabolic syndrome and Framingham risk on steatohepatitis among healthy Taiwanese: population-based nested case-control study. Cardiovasc Diabetol 2006, 5(1):12. 10.1186/1475-2840-5-12, 1481540, 16707022.
23. Chien KL, Yang CY, Lee YT. Major Gene Effects in Systolic and Diastolic Blood Pressure in the Families Receiving Health Examination in Taiwan. Journal of Hypertension 2003, 21:1-7. 10.1097/00004872-200301000-00016, 12544423.
24. Chien KL, Hsu HC, Su TC, Lee YT. Consistency in genetic inheritance mode and heritability patterns of triglyceride vs. high density lipoprotein cholesterol ratio in two Taiwanese family samples. BMC Journal Genetics 2003, 4:7-16.
25. Finke A, Kobold U, Hoelzel W, Weykamp C, Miedema K, Jeppsson JO. Preparation of a candidate primary reference material for the international standardisation of HbA1c determinations. Clin Chem Lab Med 1998, 36(5):299-308. 10.1515/CCLM.1998.051, 9676387.
26. Engelgau MM, Thompson TJ, Herman WH, Boyle JP, Aubert RE, Kenny SJ, Badran A, Sous ES, Ali MA. Comparison of fasting and 2-hour glucose and HbA1c levels for diagnosing diabetes. Diagnostic criteria and performance revisited. Diabetes Care 1997, 20(5):785-791. 10.2337/diacare.20.5.785, 9135943.
27. Hanson RL, Nelson RG, McCance DR, Beart JA, Charles MA, Pettitt DJ, Knowler WC. Comparison of screening tests for non-insulin-dependent diabetes mellitus. Arch Intern Med 1993, 153(18):2133-2140. 10.1001/archinte.153.18.2133, 8379805.
28. Griffin SJ, Little PS, Hales CN, Kinmonth AL, Wareham NJ. Diabetes risk score: towards earlier detection of type 2 diabetes in general practice. Diabetes Metab Res Rev 2000, 16(3):164-171. 10.1002/1520-7560(200005/06)16:3<164::AID-DMRR103>3.0.CO;2-R, 10867715.
29. Gaziano TA, Young CR, Fitzmaurice G, Atwood S, Gaziano JM. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort. Lancet 2008, 371(9616):923-931. 10.1016/S0140-6736(08)60418-3, 2864150, 18342687.
30. Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R. A risk score for predicting incident diabetes in the Thai population. Diabetes Care 2006, 29(8):1872-1877. 10.2337/dc05-2141, 16873795.
31. Heidemann C, Hoffmann K, Spranger J, Klipstein-Grobusch K, Mohlig M, Pfeiffer AF, Boeing H. A dietary pattern protective against type 2 diabetes in the European Prospective Investigation into Cancer and Nutrition (EPIC)--Potsdam Study cohort. Diabetologia 2005, 48(6):1126-1134. 10.1007/s00125-005-1743-1, 15889235.
32. Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE. Identifying individuals at high risk for diabetes: The Atherosclerosis Risk in Communities study. Diabetes Care 2005, 28(8):2013-2018. 10.2337/diacare.28.8.2013, 16043747.
33. Harrell FE. Regression modeling strategies with applications to linear models, logistic regression, and survival analysis. 2001, New York: Springer.
34. Sullivan LM, Massaro JM, D'Agostino RB. Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med 2004, 23(10):1631-1660. 10.1002/sim.1742, 15122742.
35. Hanley JA, McNeil BJ. A method of comparing the areas under receive operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
36. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988, 44(3):837-845. 10.2307/2531595, 3203132.
37. Hosmer DW, Lemeshow S. The multiple logistic regression model. Applied logistic regression 1989, 25-37. New York: John Wiley & Sons, 1.
38. Yates J. External correspondence: decomposition of the mean probability score. Organizational Behavior and Human Performance 1982, 30:132-156.
39. StatCorp Stata Statistical Software: Release 10. 2007, Collee Station, TX: StataCorp LP, StatCorp.
40. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007, 115(7):928-935. 10.1161/CIRCULATIONAHA.106.672402, 17309939.
41. Pencina MJ, D' Agostino RBS, D' Agostino RBJ, Vasan RS. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond. Stat Med 2008, 27(2):157-172. 10.1002/sim.2929, 17569110.
42. Schmid C, Griffith J. Multivariable classification rules: calibration and discrimination. Encyclopedia of Biostatistics 1998, Chichester, U.K.: Wiley, Armitage P, Colton T.
43. Wolf PA, D'Agostino RB, Belanger AJ, Kannel WB. Probability of stroke: a risk profile from the Framingham Study. Stroke 1991, 22(3):312-318.
44. Wilson PWF, Castelli WP, Kannel WB. Coronary risk prediction in adults (the Framingham heart study). American Journal of Cardiology 1987, 59:91G-94G. 10.1016/0002-9149(87)90165-2, 3591674.
45. D'Agostino RB, Grundy S, Sullivan LM, Wilson P. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. JAMA 2001, 286(2):180-187. 10.1001/jama.286.2.180, 11448281.
46. Glumer C, Carstensen B, Sandbaek A, Lauritzen T, Jorgensen T, Borch-Johnsen K. A Danish diabetes risk score for targeted screening: the Inter99 study. Diabetes Care 2004, 27(3):727-733. 10.2337/diacare.27.3.727, 14988293.
47. Group DPPR. Strategies to identify adults at high risk for type 2 diabetes: the Diabetes Prevention Program. Diabetes Care 2005, 28(1):138-144. 10.2337/diacare.28.1.138, 1314971, 15616247.
48. D'Agostino RB, Hamman RF, Karter AJ, Mykkanen L, Wagenknecht LE, Haffner SM. Cardiovascular disease risk factors predict the development of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes Care 2004, 27(9):2234-2240. 10.2337/diacare.27.9.2234, 15333490.
49. Davidson MB, Schriger DL, Peters AL, Lorber B. Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria. Jama 1999, 281(13):1203-1210. 10.1001/jama.281.13.1203, 10199430.
50. Lauritzen T, Griffin S, Borch-Johnsen K, Wareham NJ, Wolffenbuttel BH, Rutten G. The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with Type 2 diabetes detected by screening. Int J Obes Relat Metab Disord 2000, 24(Suppl 3):S6-11.
51. Mengual L, Roura P, Serra M, Montasell M, Prieto G, Bonet S. Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia. Cardiovasc Diabetol 2010, 9:14. 10.1186/1475-2840-9-14, 2858123, 20350315.
52. Fu AZ, Qiu Y, Radican L, Yin DD, Mavros P. Pre-existing cardiovascular diseases and glycemic control in patients with type 2 diabetes mellitus in Europe: a matched cohort study. Cardiovasc Diabetol 2010, 9:15. 10.1186/1475-2840-9-15, 2876102, 20409333.